Chimerigen Laboratories

Chimerigen Laboratories, LLC specializes in the development, manufacture, and marketing of high-quality proteins for biomedical and immunology research. Their expertise lies in producing unique immunoglobulin-based chimeric fusion proteins using advanced cellular and molecular biological techniques. These reagents are widely recognized for their performance and are frequently cited in scientific publications.

Product Portfolio:

• Immune Checkpoint Proteins: Chimerigen offers advanced proteins related to immune regulation, particularly focusing on the B7-CD28 superfamily. These proteins play crucial roles in modulating immune responses and are valuable in immunological research.
• Interleukins and Cytokines: The company provides a range of interleukins and cytokines, including non-lytic immunoglobulin-based chimeric fusion proteins. These fusion proteins combine the biological functions of cytokines with a prolonged circulating half-life, enhancing their utility in research applications.